Dosage and administration
10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
Triticum Aestivum (Wheat) Mt, Berberis Vulgaris 3X, Chelidonium Majus 3X, Taraxacum Officinale 3X, Arsenicum Album 6X, Glutathione 6X, Hepar Suis 6X, Lymph (Suis) 6X, Phosphoricum Acidum 6X, Spleen (Suis) 6X, Chelone Glabra 6X, 12X, 30X, Germanium Sesquioxide 8X, Hepatitis A Nosode 18X, 60X, 100X, Hepatitis C Nosode 18X, 60X, 100X, Hepatitis B Nosode 33X, 60X, 100X.
May assist with temporary relief of symptoms related to exposure to Hepatitis A, B or C such as fatigue, muscle and joint aches, jaundice and loss of appetite.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
If pregnant or breast-feeding, ask a health professional before use.
Do not use if tamper evident seal is broken or missing.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
May assist with temporary relief of symptoms related to exposure to Hepatitis A, B or C such as fatigue, muscle and joint aches, jaundice and loss of appetite.
Demineralized Water, 25% Ethanol
Distributed by:
SYNERGY FORMULAS, INC.
251 West Road
Campobello, SC 29322
Synergy Formulas
HEPATITIS-SODE
HOMEOPATHIC
2 FL OZ (60 ml)
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 63f39a63-5cd1-4016-bd86-2bbb0f6c3139 | Product name | 3 | 20240506 |
| e5a77e9c-c528-733a-173d-914a234c024b | Product name | 5 | 20240506 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43772-0029-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-2079-f424-e053-dadaa90a57ce | DRUG FACTS: |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43772-0029-1 | HEPATITIS-SODE | 60 mL in 1 BOTTLE, DROPPER | LIQUID | 60 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43772-0029 | HEPATITIS-SODE (TRITICUM AESTIVUM, BERBERIS VULGARIS, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, ARSENICUM ALBUM, GLUTATHIONE, HEPAR SUIS, LYMPH (SUIS), PHOSPHORICUM ACIDUM, SPLEEN (SUIS), CHELONE GLABRA, GERMANIUM SESQUIOXIDE, HEPATITIS A NOSODE, HEPATITIS C NOSODE, HEPATITIS B NOSODE) LIQUID [SYNERGY FORMULAS, INC.] | 2 | Legacy NDC, 1 package rows | 20150423_c6a1c79a-2dda-479c-8ec1-c9cade6d451b.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ARSENIC TRIOXIDE | ACTIVE INGREDIENT | S7V92P67HO | 2 | |
| BERBERIS VULGARIS ROOT BARK | ACTIVE INGREDIENT | 1TH8Q20J0U | 2 | |
| CHELIDONIUM MAJUS | ACTIVE INGREDIENT | 7E889U5RNN | 2 | |
| CHELONE GLABRA | ACTIVE INGREDIENT | 6G3UN932VF | 2 | |
| GERMANIUM SESQUIOXIDE | ACTIVE INGREDIENT | 96WE91N25T | 2 | |
| GLUTATHIONE | ACTIVE INGREDIENT | GAN16C9B8O | 2 | |
| HEPATITIS A VIRUS | ACTIVE INGREDIENT | G54MT8V18G | 2 | |
| HEPATITIS B VIRUS | ACTIVE INGREDIENT | 77H9EM77P7 | 2 | |
| HEPATITIS C VIRUS | ACTIVE INGREDIENT | QI56415283 | 2 | |
| PHOSPHORIC ACID | ACTIVE INGREDIENT | E4GA8884NN | 2 | |
| PORK LIVER | ACTIVE INGREDIENT | 6EC706HI7F | 2 | |
| SUS SCROFA LYMPH | ACTIVE INGREDIENT | 33A7VYU29L | 2 | |
| SUS SCROFA SPLEEN | ACTIVE INGREDIENT | 92AMN5J79Y | 2 | |
| TARAXACUM OFFICINALE | ACTIVE INGREDIENT | 39981FM375 | 2 | |
| TRITICUM AESTIVUM WHOLE | ACTIVE INGREDIENT | 3C3Y389JBU | 2 | |
| ARSENIC CATION (3+) | ACTIVE MOIETY | C96613F5AV | 2 | |
| BERBERIS VULGARIS ROOT BARK | ACTIVE MOIETY | 1TH8Q20J0U | 2 | |
| CHELIDONIUM MAJUS | ACTIVE MOIETY | 7E889U5RNN | 2 | |
| CHELONE GLABRA | ACTIVE MOIETY | 6G3UN932VF | 2 | |
| GERMANIUM SESQUIOXIDE | ACTIVE MOIETY | 96WE91N25T | 2 | |
| GLUTATHIONE | ACTIVE MOIETY | GAN16C9B8O | 2 | |
| HEPATITIS A VIRUS | ACTIVE MOIETY | G54MT8V18G | 2 | |
| HEPATITIS B VIRUS | ACTIVE MOIETY | 77H9EM77P7 | 2 | |
| HEPATITIS C VIRUS | ACTIVE MOIETY | QI56415283 | 2 | |
| PHOSPHORIC ACID | ACTIVE MOIETY | E4GA8884NN | 2 | |
| PORK LIVER | ACTIVE MOIETY | 6EC706HI7F | 2 | |
| SUS SCROFA LYMPH | ACTIVE MOIETY | 33A7VYU29L | 2 | |
| SUS SCROFA SPLEEN | ACTIVE MOIETY | 92AMN5J79Y | 2 | |
| TARAXACUM OFFICINALE | ACTIVE MOIETY | 39981FM375 | 2 | |
| TRITICUM AESTIVUM WHOLE | ACTIVE MOIETY | 3C3Y389JBU | 2 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43772-0029 | 43772-0029-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TRITICUM AESTIVUM WHOLE | 3C3Y389JBU | ACTIB |
| BERBERIS VULGARIS ROOT BARK | 1TH8Q20J0U | ACTIB |
| CHELIDONIUM MAJUS | 7E889U5RNN | ACTIB |
| TARAXACUM OFFICINALE | 39981FM375 | ACTIB |
| ARSENIC TRIOXIDE | S7V92P67HO | ACTIB |
| GLUTATHIONE | GAN16C9B8O | ACTIB |
| PORK LIVER | 6EC706HI7F | ACTIB |
| SUS SCROFA LYMPH | 33A7VYU29L | ACTIB |
| PHOSPHORIC ACID | E4GA8884NN | ACTIB |
| SUS SCROFA SPLEEN | 92AMN5J79Y | ACTIB |
| CHELONE GLABRA | 6G3UN932VF | ACTIB |
| GERMANIUM SESQUIOXIDE | 96WE91N25T | ACTIB |
| HEPATITIS A VIRUS | G54MT8V18G | ACTIB |
| HEPATITIS C VIRUS | QI56415283 | ACTIB |
| HEPATITIS B VIRUS | 77H9EM77P7 | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 5cd4d296-8f21-4c1d-b84b-f0a2a6a251d9 | c6a1c79a-2dda-479c-8ec1-c9cade6d451b | 2015-04-21 | Warnings | 5cd4d296-8f21-4c1d-b84b-f0a2a6a251d9 c6a1c79a-2dda-479c-8ec1-c9cade6d451b |
Adverse event summaries are temporarily unavailable. Other product information remains available.